Phase II study of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group
Tomokazu Aoki(Kitano Hospital), Nobuo Hashimoto(Kyoto University), Natsuo Oya(Kumamoto University), Masahiro Hiraoka(Kyoto University), Jun Takahashi, Kunihiko Matsui(Kumamoto University), Tetsuya Ueba(Salk Institute for Biological Studies), Tsugiya Fukui, Masatsune Ishikawa, Yasuaki Nakashima(University of Fukui)
Cited by 47
Related Papers
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function
|Proceedings of the National Academy of Sciences|2003|375
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
|European Heart Journal|2019|229
The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
|Journal of Biological Chemistry|2008|161